Resideo Technologies, Inc. REZI ← Back to all reports

Resideo Technologies, Inc.

REZI · Industrials
A ★★★★ Buy
Aug 16, 2026 · Score 90 · Type A — Value-style analysis Used for established, cash-generative companies — weighs earnings power, valuation against the company's own history and peers, and margin of safety. Full methodology →
Current PriceThe market price around the time this report was written — not a live quote. The market has moved since; check a current price before acting.Methodology → $20.46
Buy ZoneThe large figure is the midpoint of the suggested buy range shown in parentheses. $20.00 ($19.00–$21.00)
Price TargetOur estimated fair value. For richly valued stocks it can sit below the current price — see Methodology.Methodology → $35.00
Expected Return
  • Target relative to the Current Price ((Target − Current) ÷ Current). Since that price is from the report date, your actual return will differ.
  • A negative figure isn't an error. For richly valued stocks, the fair-value target can sit below the current price, so the return reads negative. The grade reflects company quality; this figure reflects today's entry valuation.
Methodology →
+71.1%

Type A - Resideo Technologies, Inc. (REZI) 20260816 Stock Analysis

📅 Resideo Key Upcoming Events

🏢 Step 1: Resideo Company Overview & Business Model

Q1-A1. What is Resideo?

Q1-A2. How Does Resideo Make Money?

Q1-A3. Resideo’s Revenue Segments & Core Income Sources

Q1-A4. Who Are Resideo’s Competitors?

Q1-A5. Resideo Key Events: Past 12 Months

Q1-A6. Step 1 Key Takeaways

🏰 Step 2: Resideo’s Economic Moat, Growth & Capital Allocation

Q2-A1. Does Resideo Have a Durable Economic Moat?

Q2-A2. Is Resideo’s Growth Sustainable?

Q2-A3. How Does Resideo Allocate Capital & Return Cash?

Q2-A4. Step 2 Key Takeaways

💰 Step 3: Is Resideo Profitable? Financial Health Analysis

Q3-A2. How Profitable Is Resideo? (Margins & ROIC)

Q3-A3. What Drives Resideo’s Returns? (ROIC Breakdown)

Q3-A4. Are Resideo’s Earnings High Quality?

Q3-A5. Is Resideo’s Balance Sheet Healthy? (Debt & Leverage)

Q3-A6. Step 3 Key Takeaways

🔎 Step 4: Resideo Forensic Accounting & Dilution Review

Q4-A1. Does Resideo Have Accounting Red Flags?

Q4-A2. Is Resideo Overspending? (Capex & Capital Cycle)

Q4-A3. How Sound Is Resideo’s Cash Flow?

Q4-A4. Is Resideo Diluting Shareholders?

Q4-A5. Data Integrity Check

Q4-A6. Step 4 Key Takeaways

👔 Step 5: Resideo Management & Shareholder Alignment

Q5-A1. Can You Trust Resideo’s Management? (Guidance Track Record)

Q5-A2. What Are Resideo Insiders Doing?

Q5-A3. Is Resideo’s Management Aligned With Shareholders?

Q5-A4. Step 5 Key Takeaways

⛵ Step 6: Resideo Market Flow & Sentiment

Q6-A1. Analyst Consensus vs Resideo Guidance

Q6-A2. What Is Resideo’s Short Interest?

Q6-A3. Step 6 Key Takeaways

🚀 Step 7: Resideo Catalysts & Price Triggers

Q7-A1. What Could Move Resideo Stock? (Top 3 Catalysts)

Q7-A2. Resideo’s Earnings Revision Trend

Q7-A3. Step 7 Key Takeaways

⚖️ Step 8: Is Resideo Fairly Valued? Valuation Analysis

Q8-A1. Resideo’s Key Valuation Multiples (P/E, EV/EBITDA)

Q8-A2. Resideo vs Peers: Valuation Comparison

Q8-A3. Is Resideo Cheap or Expensive vs Its History?

Q8-A4. What Growth Is Priced Into Resideo? (Reverse DCF)

Q8-A4-1. What Growth Hurdle Does the Market Demand From Resideo? (Reverse DCF Alternative)

Q8-A5. Valuation Cross-Check

Q8-A6. Resideo’s Hidden Asset & Stake Valuation

Q8-A7. Final Valuation Adjustment

Q8-A8. Valuation Adjustment Score Calculation

💀 Step 9: What Are the Risks of Resideo? Fatal Risks & Pre-Mortem

Q9-A1. What Are the Biggest Risks to Resideo?

Q9-A2. How Sensitive Is Resideo to the Economy?

Q9-A3. Resideo Pre-Mortem: What Could Go Wrong?

Q9-A4. Risk Adjustment Score

🎯 Step 10: Resideo Final Verdict: Score & Rating

Q10-A1. Investment Score & Rating

Q10-A2. Should You Buy Resideo? (Recommendation)

Q10-A3. Investment Thesis in One Line

Q10-A4. Resideo’s Price Trend & Key Drivers

Q10-A5. Action Plan

🕵️‍♂️ Deep Dive Analysis

Q1: Is Resideo’s Elevated Standalone Leverage Following the ADI Spin-Off Its Biggest Weakness?

Q2: Can Resideo’s 12.9x Forward P/E Be Justified as It Transitions to a Pure-Play Building Technology Company?

Q3: Will the Confirmed $40 to $50 Million OEM Security Customer Loss Permanently Damage Margins?

Q4: Does the $1.59 Billion Buyout of the Honeywell Indemnification Agreement Prove Transformational for Free Cash Flow?

Q5: Can the Products & Solutions Segment Sustain Its 13-Quarter Gross Margin Expansion Streak Amidst Global Tariff Threats?

Q6: How Dangerous Is the Downward Adjustment of CD&R’s Preferred Stock Conversion Price to Common Shareholders?

Q7: Will U.S. Housing Market Stagnation Choke Off Resideo’s Core Repair and Remodel Volume?

Q8: Does the Elevation of Thomas Surran to Chief Executive Officer Signal a Shift Toward Aggressive Organic Innovation?

Q9: Can the New Mid-Year Global Security Platform Effectively Backfill the Lost OEM Revenue?

Q10: Is the Wholesale Eradication of the Term Loan B Debt the Primary Catalyst for Near-Term Equity Rerating?